Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MDU | PHI |
|---|---|---|
| Price | $18.69 | $18.15 |
| Change today | ▲ 0.43% | ▲ 3.36% |
| Market cap | $3.93B | $3.92B |
| Return, 3 months | -9.2% | +3.8% |
| Return, year to date | -2.2% | -9.8% |
| Return, 1 year | +7.3% | +3.9% |
| P/E (TTM) | 19.7 | 8.9 |
| P/B | 1.3 | 1.8 |
| P/E percentile vs own 5y | 82nd | 21st |
| Dividend yield | 3.00% | 8.48% |
| Revenue growth (YoY, latest qtr) | – | +0.7% |
| Net profit growth (YoY) | – | -6.7% |
| Gross margin | – | 85.8% |
| Operating margin | – | 23.9% |
| Net margin | – | 12.5% |
| Return on equity | – | 21.5% |
| Analyst target vs. price | +33.8% | – |
| Analyst buy share | 100% | – |
| RSI (14) | 42 | 55 |
| 30-day volatility | 15.1% | 27.7% |
| Max drawdown, 1 year | -18.2% | -26.5% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
